As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months after they are sent. Business owners have 15 days to respond to FDA warning letters. Warning letters often are

Continue Reading FDA sends warning to food firm with CBD and THC in products over risk of unintended consumption

CBD, the second most prevalent active ingredient in marijuana, is readily obtainable just about everywhere in the United States. By itself, it does not cause a “high” and the World Health Organization finds no evidence of public health-related problems associated with the use of pure CBD.

The U.S. Food and

Continue Reading FDA decides CBD products have unknown dangers that Congress should look at

Cannabidiol (CBD) oil has been recalled in Ireland after being made in an unregistered establishment.

Hugold CBD Oils were recalled after they were processed at a site were operations had not been reported to authorities.

Also, the products contain concentrated CBD which is an unauthorized novel food. A novel food
Continue Reading Unapproved product, facility prompts CBD recall; other enforcement activities reported